Endocarditis 2

download Endocarditis 2

of 38

Transcript of Endocarditis 2

  • 7/27/2019 Endocarditis 2

    1/38

    Infective Endocarditis

    Suhail Allaqaband

    Sinai Samaritan Medical Center

    Milwaukee, WI

  • 7/27/2019 Endocarditis 2

    2/38

    EPIDEMIOLOGY

    An estimated 10,000 to 15,000 new cases of IE are

    diagnosed in the United States each year

    IE has increasingly become a disease of the elderly

    More than one-half of all IE cases in the United States

    now occur in patients over the age of 60

    This trend is probably due to two factors

    the decline in the incidence of rheumatic heart disease the increasing proportion of elderly subjects in the general

    population

  • 7/27/2019 Endocarditis 2

    3/38

    RISK FACTORS

    Injection drug use

    Highest risk factor in patients < 40 years of age

    Prosthetic heart valves

    Prosthetic valve endocarditis comprises a smallbut important segment of IE cases

    More than 100,000 heart valves are implanted

    annually in the United StatesIE develops in 1 to 4 % of valve recipients during

    the 1st year following valve replacement, and in

    approximately 1 percent per year thereafter

  • 7/27/2019 Endocarditis 2

    4/38

    RISK FACTORS

    Nosocomial endocarditisUsually a complication of bacteremia induced by an

    invasive procedure or a vascular device

    Structural heart diseaseApproximately three-fourths of all patients with IE

    have a preexisting structural cardiac abnormality

    Congenital heart disease is present in 10-20% cases

    The most common predisposing congenital heart

    lesions are bicuspid aortic valves, PDA, VSD,

    coarctation of the aorta, and tetralogy of Fallot

  • 7/27/2019 Endocarditis 2

    5/38

    RISK FACTORS

    Degenerative valvular lesions

    The risk of IE in patients with MVP and

    associated regurgitation is estimated to be 5 to 8

    times higher than that in the normal population

    Aortic valve disease(stenosis or/and

    regurgitation) is present in 12 to 30 percent of

    cases

  • 7/27/2019 Endocarditis 2

    6/38

    RISK FACTORS

    History of infective endocarditisRecurrent endocarditis occurred in 4.5 percent of

    one large cohort of non-addicts

    Other studies have reported rates of IE recurrence

    ranging from 2.5 to 9 percent

    HIV infection

    A number of cases of IE have been reported in

    patients with HIV infection

    It has been suggested that HIV infection is an

    independent risk factor for IE in IV drug abusers

  • 7/27/2019 Endocarditis 2

    7/38

    A number of other, less common

    predisposing factors for IE include Pregnancy

    AV fistulas used for hemodialysis

    Central venous and pulmonary artery catheters

    Peritoneovenous shunts for the control of ascites Ventriculoatrial shunts for the management of

    hydrocephalus

    In addition, patients with ulcerative lesions of the

    colon due to carcinoma or inflammatory boweldisease have a poorly understood predilection to

    develop endocarditis secondary to Strep.bovis

  • 7/27/2019 Endocarditis 2

    8/38

    Case Definition

    Duke criteria

    In 1994 investigators from Duke University

    modified the previous criteria to include the

    role of echocardiography in diagnosis

    They also expanded the category of

    predisposing heart conditions to include

    intravenous drug use

  • 7/27/2019 Endocarditis 2

    9/38

    Duke Criteria

    Definitive infective endocarditispathologic criteria

    microorganisms : demonstrated by culture or

    histology in a vegetation, or in a vegetation that has

    embolized, or in an intracardiac abscess or

    Pathologic Lesions : vegetation or intracardiac

    abscess, confirmed by histology

    clinical criteria

    two major criteria, or

    one major and three minor criteria, or

    five minor criteria

  • 7/27/2019 Endocarditis 2

    10/38

    Duke Criteria

    Possible infective endocarditis findings consistent of IE that fall short of definite, but

    not rejected

    Rejected firm alternate Dx for manifestation of IE

    resolution of manifestations of IE, with antibiotic

    therapy for

    4 days no pathologic evidence of IE at surgery or autopsy, after

    antibiotic therapy for 4 days

  • 7/27/2019 Endocarditis 2

    11/38

    Duke Criteria

    Major criteria

    positive blood culture for IE

    evidence of endocardial involvement

    Minor criteria

    predisposition (heart condition or IV drug use)

    fever of 100.40F or higher

    vascular or immunologic phenomena microbiologic or echocardiographic evidence not

    meeting major criteria

  • 7/27/2019 Endocarditis 2

    12/38

    Major Criteria

    Positive blood culture for IE typical microorganism for IE from two separate blood

    cultures in the absence of a primary focus

    strep viridans, strep bovis, HACEK group, staphaureus or enterococci

    Persistently positive blood culture

    blood cultures drawn more than 12 hr apart, or all of 3 or a majority of 4 or more separate blood

    cultures, with first and last drqwn at least 1 hr apart

  • 7/27/2019 Endocarditis 2

    13/38

    Major Criteria

    Evidence of endocardial involvement

    positive echocardiogram for endocarditis

    oscillating intracardiac mass on valve or supporting

    structure, or in the path of regurgitant jets, or on

    implanted material, in the absence of an alternate

    anatomic explanation

    abscess

    new partial dehiscence of prosthetic valve

    new valvular regurgitation (increase or change inpre-existing murmur not sufficient)

  • 7/27/2019 Endocarditis 2

    14/38

    Minor Criteria

    predisposition

    predisposing heart condition or iv drug use

    fever of 100.40F or higher

    vascular phenomena

    major arterial emboli

    septic pulmonary infarcts

    mycotic aneurysm intracranial hemorrhage

    conjunctive hemorrhages

    Janeway lesions

  • 7/27/2019 Endocarditis 2

    15/38

    Dukes Minor Criteria

    immunologic phenomena

    Glomerulonephritis

    Rheumatoid factor

    microbiologic evidence

    positive blood culture not meeting major criteria or

    serologic evidence of active infection with organism

    consistent with IE

    echocardiogram

    consistent with IE but not meeting major criteria

    Oslers nodes

    Roth spots

  • 7/27/2019 Endocarditis 2

    16/38

    Validity of Duke criteria

    405 consecutive cases of suspected IE were studied 69 cases of IE were confirmed pathologically

    55 (80 percent) were clinically classified as definite

    using the Duke criteria, versus only 35 being

    classified as probable by the von Reyn criteria

    12 of the pathologically confirmed cases were

    "rejected" by the von Reyn criteria whereas none by

    the Duke criteriaNew criteria for diagnosis of infective endocarditis:

    Utilization of specific echocardiographic findings.

    Duke Endocarditis Service Am J Med 1994; 96:200

  • 7/27/2019 Endocarditis 2

    17/38

    Diagnostic approach to infective endocarditis

    History A careful history should be performed with special attention

    given to a history of prior cardiac lesions and historical clues

    pointing toward a recent source of bacteremia

    Physical examination A meticulous clinical examination should be performed

    looking for clinical evidence of small and large emboli with

    special attention to the fundi, conjunctivae, skin, and digits

    Cardiac examination may reveal signs of new regurgitantmurmurs and signs of CHF

    Neurologic evaluation may detect evidence of focal neurologic

    impairment

  • 7/27/2019 Endocarditis 2

    18/38

    Diagnostic approach to infective endocarditis

    Positive blood culture resultsA minimum of three blood cultures should be

    obtained over a time period based upon the severity

    of the illness

    Additional laboratory tests

    An elevated ESR and/or an elevated level of CRP

    is usually present

    Most patients quickly develop a normochromicnormocytic anemia

    The WBC count may be normal or elevated

  • 7/27/2019 Endocarditis 2

    19/38

    Diagnostic approach to infective endocarditis

    Additional laboratory tests elevated levels of serum globulins

    presence of cryoglobulins and circulating immune complexes

    hypocomplementemia

    false positive serologic tests for syphilis

    abnormal urinalysis

    microscopic or gross hematuria, proteinuria, or pyuria

    the combination of RBC casts on urinalysis and a low serumcomplement level may be an indicator of immune-mediated

    glomerular disease

  • 7/27/2019 Endocarditis 2

    20/38

    Diagnostic approach to infective endocarditis

    Electrocardiogram

    All patients with suspected IE should have an

    EKG to determine whether there is evidence of

    heart block or a conduction delay and to

    establish a baseline should such a complication

    develop later

  • 7/27/2019 Endocarditis 2

    21/38

    Diagnostic approach to infective endocarditis

    Echocardiography

    Should be performed in all patients with suspected IE

    A TTE should initially be obtained in patients with

    native heart valves, while those with prosthetic valvesshould undergo TEE

    Detection of a vegetation by TTE is a positive test

    However, a negative study does not preclude the

    diagnosis and should be followed by TEE, when there

    is an intermediate or high suspicion of IE

  • 7/27/2019 Endocarditis 2

    22/38

    Improved diagnostic value of echocardiography in patients

    with infective endocarditis by transoesophageal approach

    A prospective study.Eur Heart J 1988 Jan;9(1):43-53

    96 patients were studied consecutively with TEE and

    TTE

    TEE had a sensitivity for the detection of vegetationsof 100 percent as compared to 63 percent with TTE

    Both TTE and TEE had specificity of 98%

    Only 25% of vegetations less than 5 mm, 69% of

    vegetations 6-10 mm, and 100% of vegetationsgreater than 11 mm detected by TEE were also

    observed with TTE

  • 7/27/2019 Endocarditis 2

    23/38

    Major Pathogens

    Native Valve IE

    Strep.(55%), mostly Viridans

    Staph.(30%), mostly S.aureus

    Entrococci(5-10%) Prosthetic Valve IE

    Early (0-2 months)

    Staph(50%)- mostly S.epi.

    IE in IV drug abusers

    Staph. aureus(50-60%)

    Late (>60 days)

    Staph(30%)

  • 7/27/2019 Endocarditis 2

    24/38

    Treatment of infective endocarditis

    GENERAL CONSIDERATIONS

    Antimicrobial therapy should be administered

    in a dose designed to give sustained bactericidal

    serum concentrations throughout much or all of

    the dosing interval

    In vitro determination of the minimum

    inhibitory concentration of the etiologic causeof the endocarditis should be performed in all

    patients

  • 7/27/2019 Endocarditis 2

    25/38

    Treatment of infective endocarditis

    GENERAL CONSIDERATIONS

    The duration of therapy has to be sufficient to

    eradicate microorganisms growing within thevalvular vegetations

    The need for prolonged therapy in treating

    endocarditis has stimulated interest in using

    combination therapy to treat endocarditis

  • 7/27/2019 Endocarditis 2

    26/38

    VIRIDANS STREPTOCOCCI AND STREP. BOVIS

    Antibiotic Dosage and route Duration Comments

    Aqueous crystalline 12-18 million U/24 h 4 wks preferred in most patients older than 65 yrspenicillin G sodium IV either continuously and in those with impairment of the eighth

    or in 6 = divided doses nerve or renal function

    or

    Ceftriaxone sodium 2g once daily IV or IM 2 wks

    Aqueous crystalline 12-18 million U/24 h 2 wks when obtained 1h after a 20-30 min.

    penicillin G sodium IV either continuously IV infusion or IM injection, serumor in six equally concentration of gentamicin of

    divided doses approximately 3 mcg/mL is desirable;

    with gentamicin 1 g IM or IV every 8 h 2 wks trough concentration should be < 1 pg/mL

    sulfate

    Vancomycin 30 mg/kg per 24 h IV 4 wks vancomycin therapy is recommended for

    hydrochloride in two equally divided patients allergic to beta lactams; peak

    doses, not to exceed 2 serum concentrations of vancomycin should

    gram/24h unless serum be obtained one h after completion of the

    levels are monitored infusion and should be in the range of

    30-45 mcg/mL for twice-daily dosing

    JAMA 1995; 274:1706

    ENTEROCOCCI

  • 7/27/2019 Endocarditis 2

    27/38

    ENTEROCOCCI

  • 7/27/2019 Endocarditis 2

    28/38

    STAPH. ENDOCARDITIS IN NATIVE VALVES

  • 7/27/2019 Endocarditis 2

    29/38

    STAPH. ENDOCARDITIS IN PROSTHETIC VALVES

  • 7/27/2019 Endocarditis 2

    30/38

    HACEK ORGANISMS

  • 7/27/2019 Endocarditis 2

    31/38

    Indications for surgery in IE The indications for surgery in patients with native-valve

    IE and prosthetic-valve IE are essentially the same

    Surgery is warranted for patients with active IE who

    have one or more of the following complications:CHF that is directly related to valve dysfunction

    Persistent or uncontrolled infection while receiving

    appropriate antimicrobial therapy, includingevidence of perivalvular extension

    Recurrent emboli, particularly in the presence of

    large vegetations

  • 7/27/2019 Endocarditis 2

    32/38

    Indications for surgery in IE

    Relative indications for surgeryEvidence of perivalvular infection, such as

    intracardiac abscess or fistula formation

    Rupture of a sinus of Valsalva aneurysmFungal endocarditis

    Endocarditis due to highly resistant microorganism

    Relapse after a course of adequate antimicrobialtherapy, particularly in prosthetic valve endocarditis

    Culture-negative IE with fever more than 10 days

    after starting empirical therapy

  • 7/27/2019 Endocarditis 2

    33/38

    Indications for surgery in prosthetic

    valve IE Same as native valve endocarditis

    Perivalvular infection

    Valve Dehiscence

    excessively mobile prosthesis on echo

    results in hemodynamic instability

  • 7/27/2019 Endocarditis 2

    34/38

    OUTCOME OF SURGERY The outcome of surgery in patients with IE has been

    good, particularly when surgical treatment is radical

    with the removal of all infected and necrotic tissue

    In a recent study of 138 patients who underwent valve

    surgery in the presence of active infection, the earlymortality, due to heart failure or septic multiorgan

    failure, was 11.5 %

    Risk factors for early mortality were NYHA class IV

    or cardiogenic shock, advanced age, preoperativeacute renal failure, and staphylococcal infection

    Operation for infective endocarditis: Results after implantation

    of mechanical valves. Ann Thorac Surg 1998; 65:359.

    recommen a on or surgery n pa en s w

  • 7/27/2019 Endocarditis 2

    35/38

    recommen a on or surgery n pa en s w

    native valve endocarditis

    ACC/AHA recommendation for surgery in patients with

  • 7/27/2019 Endocarditis 2

    36/38

    ACC/AHA recommendation for surgery in patients with

    prosthetic valve endocarditis

  • 7/27/2019 Endocarditis 2

    37/38

    ACC/AHA recommendation for valve replacement with

    mechanical prosthesis

  • 7/27/2019 Endocarditis 2

    38/38

    ACC/AHA recommendation for

    valve replacement with bioprosthesis